Clinical Trials Directory

Trials / Completed

CompletedNCT00784498

Procedural Sedation Using Propofol Versus Midazolam/Ketamine in the Adult Emergency Department

Procedural Sedation for Painful Orthopedic Manipulations With Propofol vs. Midazolam/Ketamine in the Adult Emergency Department

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Tel-Aviv Sourasky Medical Center · Other Government
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The use of procedural sedation and analgesia (PSA) to accomplish painful procedures in the emergency department (ED) has become a standard of practice over the last decade. Substantial variance exists regarding usage of medication for PSA, and many anesthetic agents have been proposed for this use. To our knowledge no head to head study compared the clinical effectiveness, safety profile and amnestic properties of midazolam/ketamine vs. propofol regimens for PSA in the adult ED setting. This prospective randomized trail can will help to evaluate the effectiveness and safety profile of Midazolam/katamine regimen for ED PSA in adults and will contribute to the discussion regarding propofol roll in the ED.

Conditions

Interventions

TypeNameDescription
DRUGKetamine/MidazolamIntravenous bolus of midazolam 0.1mg/kg in titrated dose of 1 mg/min until spontaneous eye closure or up to 5mg (whichever comes first) followed by ketamine 0.5-1mg/kg (up to 100mg) in titrated dose of 10mg/30 seconds, to achieve the desired level of sedation
DRUGPropofolIntravenous bolus of propofol 0.5-1mg/kg in titrated dose of 10mg/30seconds (up to 100mg) to achieve the desired level of sedation

Timeline

Start date
2008-11-01
Primary completion
2009-09-01
Completion
2009-09-01
First posted
2008-11-04
Last updated
2010-08-03

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00784498. Inclusion in this directory is not an endorsement.